Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2026 Filed May 21, 2026 20:20 UTC |
Matheis DennisDirector
|
PurchaseCommon Stock | 245,000 | $1.00 | $245,269.50 |
DisclosureSEC source: 0001094891-26-000217 · form4.xml · nonDerivative · entry 1 Matheis Dennis · CIK 0001817012 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,033,443 F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.9375 to $1.0200, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:57 UTC |
Matheis DennisDirector
|
GrantCommon Stock | 123,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000080 · form4.xml · nonDerivative · entry 1 Matheis Dennis · CIK 0001817012 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 788,443 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:51 UTC |
Sparks Ronald MDirector
|
GrantCommon stock | 123,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000077 · form4.xml · nonDerivative · entry 1 Sparks Ronald M · CIK 0001665394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,460 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 00:00 UTC |
Aklog LishanDirector · Chief Executive Officer
|
GrantCommon Stock | 2,170,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000083 · form4.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,636,627 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:52 UTC |
White DebraDirector
|
GrantCommon Stock | 123,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000078 · form4.xml · nonDerivative · entry 1 White Debra · CIK 0001859882 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,800 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:48 UTC |
SOKOLOV JACQUE JDirector
|
GrantCommon Stock | 123,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000074 · form4.xml · nonDerivative · entry 1 SOKOLOV JACQUE J · CIK 0001282803 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,460 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:47 UTC |
PALUMBO JOHN RDirector
|
GrantCommon Stock | 123,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000073 · form4.xml · nonDerivative · entry 1 PALUMBO JOHN R · CIK 0001251475 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,000 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:44 UTC |
Lapidus StanleyDirector
|
GrantCommon Stock | 123,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000070 · form4.xml · nonDerivative · entry 1 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 337,392 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:30 UTC |
MCGRATH DENNIS MChief Financial Officer
|
GrantCommon stock | 470,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000062 · form4.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,813,569 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:42 UTC |
Cox James LDirector
|
GrantCommon Stock | 123,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000068 · form4.xml · nonDerivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405,120 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:29 UTC |
O'Neil ShaunPresident and COO
|
GrantCommon stock | 620,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000060 · form4.xml · nonDerivative · entry 1 O'Neil Shaun · CIK 0001908075 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,446,763 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:25 UTC |
Gordon Michael AdamGeneral Counsel and Secretary
|
GrantCommon stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000058 · form4.xml · nonDerivative · entry 1 Gordon Michael Adam · CIK 0001932934 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| October 06, 2025 Filed Oct 7, 2025 20:46 UTC |
PALUMBO JOHN RDirector
|
GrantEmployee stock option (right to buy) · Derivative | 215,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001094891-25-000050 · form4.xml · derivative · entry 1 PALUMBO JOHN R · CIK 0001251475 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,000 Underlying: Common Stock · 215,000 shares Expires 2035-10-06 F1 · derivative.exercise_date: The option was granted pursuant to the issuer's Amended and Restated 2018 Long-Term Incentive Equity Plan. One third of the option vests on June 30, 2026 and the balance vests in eight equal quarterly installments, starting September 30, 2026 and ending on June 30, 2028. Read SEC document |
| August 20, 2025 Filed Aug 22, 2025 21:17 UTC |
Matheis DennisDirector
|
PurchaseCommon Stock | 100,000 | $1.02 | $101,840.00 |
DisclosureSEC source: 0001062993-25-014853 · form4.xml · nonDerivative · entry 1 Matheis Dennis · CIK 0001817012 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 665,443 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.0085 to $1.0286. inclusive. The reporting person undertakes to provide to Lucid Diagnostics Inc., any security holder of Lucid Diagnostics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 22, 2025 Filed May 22, 2025 20:45 UTC |
Matheis DennisDirector
|
PurchaseCommon Stock | 33,218 | $1.32 | $43,794.61 |
DisclosureSEC source: 0001062993-25-010111 · form4.xml · nonDerivative · entry 3 Matheis Dennis · CIK 0001817012 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.305 to $1.32, inclusive. Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:14 UTC Amendment |
Matheis DennisDirector
|
PurchaseCommon Stock | 33,218 | $1.32 | $43,794.61 |
DisclosureSEC source: 0001062993-25-010245 · form4a.xml · nonDerivative · entry 3 Matheis Dennis · CIK 0001817012 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 565,443 F3 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.305 to $1.32, inclusive. Read SEC document |
| May 21, 2025 Filed May 22, 2025 20:45 UTC |
Matheis DennisDirector
|
PurchaseCommon Stock | 129,684 | $1.32 | $171,520.06 |
DisclosureSEC source: 0001062993-25-010111 · form4.xml · nonDerivative · entry 2 Matheis Dennis · CIK 0001817012 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,782 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.315 to $1.32, inclusive. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:14 UTC Amendment |
Matheis DennisDirector
|
PurchaseCommon Stock | 129,684 | $1.32 | $171,520.06 |
DisclosureSEC source: 0001062993-25-010245 · form4a.xml · nonDerivative · entry 2 Matheis Dennis · CIK 0001817012 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 532,225 F2 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.315 to $1.32, inclusive. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:45 UTC |
Matheis DennisDirector
|
PurchaseCommon Stock | 187,098 | $1.30 | $242,291.91 |
DisclosureSEC source: 0001062993-25-010111 · form4.xml · nonDerivative · entry 1 Matheis Dennis · CIK 0001817012 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,098 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.265 to $1.30. inclusive. The reporting person undertakes to provide to Lucid Diagnostics Inc., any security holder of Lucid Diagnostics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form4. Read SEC document |
| May 20, 2025 Filed May 23, 2025 20:14 UTC Amendment |
Matheis DennisDirector
|
PurchaseCommon Stock | 187,098 | $1.30 | $242,291.91 |
DisclosureSEC source: 0001062993-25-010245 · form4a.xml · nonDerivative · entry 1 Matheis Dennis · CIK 0001817012 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402,541 F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.265 to $1.30. inclusive. The reporting person undertakes to provide to Lucid Diagnostics Inc., any security holder of Lucid Diagnostics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form4. F4 · ownership.direct: Includes 52,718 shares of Lucid common stock distributed on a pro rata basis to the reporting person by a limited partnership of which the reporting person is a limited partner. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 22:19 UTC |
Matheis DennisDirector
|
GrantCommon Stock | 112,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003184 · form4.xml · nonDerivative · entry 1 Matheis Dennis · CIK 0001817012 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,725 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 22:56 UTC |
O'Neil ShaunPresident and COO
|
GrantCommon stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003236 · form4.xml · nonDerivative · entry 1 O'Neil Shaun · CIK 0001908075 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 826,763 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. F2 · balance_after: Includes 6,763 shares of Lucid common stock distributed by PAVmed on February 15, 2024 to Mr. O'Neil, representing his share of the shares of Lucid common stock distributed by PAVmed to its shareholders on a pro rata basis on such date. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 22:46 UTC |
Aklog LishanDirector · Chief Executive Officer
|
GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003218 · form4.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,466,627 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. F2 · balance_after: Includes 142,227 shares of Lucid common stock distributed by PAVmed on February 15, 2024 to Dr. Aklog, representing his share of the shares of Lucid common stock distributed by PAVmed to its shareholders on a pro rata basis on such date. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 22:36 UTC |
SOKOLOV JACQUE JDirector
|
GrantCommon Stock | 112,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003202 · form4.xml · nonDerivative · entry 1 SOKOLOV JACQUE J · CIK 0001282803 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,460 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 22:28 UTC |
Lapidus StanleyDirector
|
GrantCommon Stock | 112,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003193 · form4.xml · nonDerivative · entry 1 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,392 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 22:08 UTC |
Cox James LDirector
|
GrantCommon Stock | 112,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003174 · form4.xml · nonDerivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,120 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 22:03 UTC |
MCGRATH DENNIS MChief Financial Officer
|
GrantCommon stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003171 · form4.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,343,569 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. F2 · balance_after: Includes 19,169 shares of Lucid common stock distributed by PAVmed on February 15, 2024 to Mr. McGrath, representing his share of the shares of Lucid common stock distributed by PAVmed to its shareholders on a pro rata basis on such date. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 21:46 UTC |
White DebraDirector
|
GrantCommon Stock | 112,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003165 · form4.xml · nonDerivative · entry 1 White Debra · CIK 0001859882 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,800 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 21:58 UTC |
Gordon Michael AdamGeneral Counsel and Secretary
|
GrantCommon stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003169 · form4.xml · nonDerivative · entry 1 Gordon Michael Adam · CIK 0001932934 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700,000 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 21:42 UTC |
Sparks Ronald MDirector
|
GrantCommon stock | 112,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003163 · form4.xml · nonDerivative · entry 1 Sparks Ronald M · CIK 0001665394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,460 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed Read SEC document |
| May 08, 2024 Filed May 10, 2024 01:58 UTC |
Matheis DennisDirector
|
GrantEmployee stock option (right to buy) · Derivative | 241,500 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001062993-24-009828 · form4.xml · derivative · entry 1 Matheis Dennis · CIK 0001817012 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,500 Underlying: Common stock · 241,500 shares Expires 2034-05-08 F1 · derivative.exercise_date: One third of the option vests on December 31, 2024; the balance vests in eight equal quarterly installments, starting March 31, 2025. Read SEC document |
| May 07, 2024 Filed May 8, 2024 20:01 UTC |
Gordon Michael AdamGeneral Counsel and Secretary
|
GrantCommon stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009640 · form4.xml · nonDerivative · entry 1 Gordon Michael Adam · CIK 0001932934 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2026. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| May 07, 2024 Filed May 8, 2024 20:01 UTC |
O'Neil ShaunPresident and COO
|
GrantCommon stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009639 · form4.xml · nonDerivative · entry 1 O'Neil Shaun · CIK 0001908075 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 526,763 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2026. Such restricted stock is subject to forfeiture if the requisite service period is not completed. F2 · balance_after: Includes 6,763 shares of Lucid common stock distributed by PAVmed on February 15, 2024 to Mr. O'Neil, representing his share of the shares of Lucid common stock distributed by PAVmed to its shareholders on a pro rata basis on such date. Read SEC document |
| May 07, 2024 Filed May 8, 2024 20:01 UTC |
MCGRATH DENNIS MChief Financial Officer
|
GrantCommon stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009638 · form4.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,043,569 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2026. Such restricted stock is subject to forfeiture if the requisite service period is not completed. F2 · balance_after: Includes 19,169 shares of Lucid common stock distributed by PAVmed on February 15, 2024 to Mr. McGrath, representing his share of the shares of Lucid common stock distributed by PAVmed to its shareholders on a pro rata basis on such date. Read SEC document |
| May 07, 2024 Filed May 8, 2024 20:00 UTC |
Aklog LishanDirector · Chief Executive Officer
|
GrantCommon stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009637 · form4.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,166,627 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2026. Such restricted stock is subject to forfeiture if the requisite service period is not completed. F2 · balance_after: Includes 142,227 shares of Lucid common stock distributed by PAVmed on February 15, 2024 to Dr. Aklog, representing his share of the shares of Lucid common stock distributed by PAVmed to its shareholders on a pro rata basis on such date. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:49 UTC |
White DebraDirector
|
GrantEmployee stock option (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001062993-24-004287 · form4.xml · derivative · entry 1 White Debra · CIK 0001859882 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common stock · 150,000 shares Expires 2034-02-22 F1 · derivative.exercise_date: One third of the option vests on December 31, 2024; the balance vests in eight equal quarterly installments, starting March 31, 2025. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:48 UTC |
Sparks Ronald MDirector
|
GrantEmployee stock option (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001062993-24-004286 · form4.xml · derivative · entry 1 Sparks Ronald M · CIK 0001665394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common stock · 150,000 shares Expires 2034-02-22 F1 · derivative.exercise_date: One third of the option vests on December 31, 2024; the balance vests in eight equal quarterly installments, starting March 31, 2025. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:48 UTC |
Lapidus StanleyDirector
|
GrantEmployee stock option (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001062993-24-004285 · form4.xml · derivative · entry 1 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common stock · 150,000 shares Expires 2034-02-22 F1 · derivative.exercise_date: One third of the option vests on December 31, 2024; the balance vests in eight equal quarterly installments, starting March 31, 2025. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:46 UTC |
Cox James LDirector
|
GrantEmployee stock option (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001062993-24-004284 · form4.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common stock · 150,000 shares Expires 2034-02-22 F1 · derivative.exercise_date: One third of the option vests on December 31, 2024; the balance vests in eight equal quarterly installments, starting March 31, 2025. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:37 UTC |
SOKOLOV JACQUE JDirector
|
GrantEmployee stock option (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001062993-24-004273 · form4.xml · derivative · entry 1 SOKOLOV JACQUE J · CIK 0001282803 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common stock · 150,000 shares Expires 2034-02-22 F1 · derivative.exercise_date: One third of the option vests on December 31, 2024; the balance vests in eight equal quarterly installments, starting March 31, 2025. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:49 UTC |
PAVmed Inc.10% owner
|
OtherCommon Stock | 3,331,747 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-24-003693 · form4.xml · nonDerivative · entry 1 PAVmed Inc. · CIK 0001624326 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,302,444 F1 · kind: Distribution by the Reporting Person as a pro rata dividend to the owners of common and preferred stock of the Reporting Person. F1 · price: Distribution by the Reporting Person as a pro rata dividend to the owners of common and preferred stock of the Reporting Person. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 22:29 UTC |
PAVmed Inc.10% owner
|
OtherCommon Stock | 3,331,771 | $1.40 | $4,675,474.24 |
DisclosureSEC source: 0001062993-24-001613 · form4.xml · nonDerivative · entry 1 PAVmed Inc. · CIK 0001624326 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,634,191 F1 · kind: Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement. Read SEC document |
| September 26, 2023 Filed Sep 28, 2023 00:53 UTC |
Lapidus StanleyDirector
|
SaleCommon stock | 9,747 | $1.45 | $14,133.15 |
DisclosureSEC source: 0001062993-23-018552 · form4.xml · nonDerivative · entry 4 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,592 F1 · kind: Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock. F2 · balance_after: Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023. F3 · ownership.direct: The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023. Read SEC document |
| September 26, 2023 Filed Sep 28, 2023 00:53 UTC |
Lapidus StanleyDirector
|
SaleCommon stock | 10,000 | $1.43 | $14,300.00 |
DisclosureSEC source: 0001062993-23-018552 · form4.xml · nonDerivative · entry 3 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,339 F1 · kind: Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock. F2 · balance_after: Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023. F3 · ownership.direct: The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023. Read SEC document |
| September 26, 2023 Filed Sep 28, 2023 00:53 UTC |
Lapidus StanleyDirector
|
SaleCommon stock | 10,000 | $1.47 | $14,740.00 |
DisclosureSEC source: 0001062993-23-018552 · form4.xml · nonDerivative · entry 2 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,339 F1 · kind: Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock. F2 · balance_after: Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023. F3 · ownership.direct: The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023. Read SEC document |
| September 25, 2023 Filed Sep 28, 2023 00:53 UTC |
Lapidus StanleyDirector
|
SaleCommon stock | 200 | $1.43 | $286.00 |
DisclosureSEC source: 0001062993-23-018552 · form4.xml · nonDerivative · entry 1 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 131,339 F1 · kind: Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock. F2 · balance_after: Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023. F3 · ownership.direct: The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023. Read SEC document |
| September 21, 2023 Filed Sep 22, 2023 22:39 UTC |
Lapidus StanleyDirector
|
SaleCommon stock | 100 | $1.44 | $144.00 |
DisclosureSEC source: 0001062993-23-018421 · form4.xml · nonDerivative · entry 3 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,539 F1 · kind: Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock. F2 · balance_after: Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023. Read SEC document |
| September 21, 2023 Filed Sep 28, 2023 00:50 UTC Amendment |
Lapidus StanleyDirector
|
SaleCommon stock | 100 | $1.44 | $144.00 |
DisclosureSEC source: 0001062993-23-018551 · form4a.xml · nonDerivative · entry 3 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 131,539 F1 · kind: Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock. F2 · balance_after: Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023. F3 · ownership.direct: The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023. Read SEC document |
| September 20, 2023 Filed Sep 22, 2023 22:39 UTC |
Lapidus StanleyDirector
|
SaleCommon stock | 412 | $1.44 | $593.28 |
DisclosureSEC source: 0001062993-23-018421 · form4.xml · nonDerivative · entry 2 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,639 F1 · kind: Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock. F2 · balance_after: Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023. Read SEC document |
| September 20, 2023 Filed Sep 22, 2023 22:39 UTC |
Lapidus StanleyDirector
|
SaleCommon stock | 3,405 | $1.45 | $4,937.25 |
DisclosureSEC source: 0001062993-23-018421 · form4.xml · nonDerivative · entry 1 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,051 F1 · kind: Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock. F2 · balance_after: Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.